Vitrolife AB

Equities

VITR

SE0011205202

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm Other stock markets 11:29:32 2024-04-26 am EDT			5-day change	1st Jan Change
163.3 ^SEK	+3.62%		-0.24%	-16.13%

Apr. 25	Vitrolife AB Approves Dividend for the Financial Year 2023	CI
Apr. 18	Nordic Stocks Closed Down Thursday; Arjo Series B Fell Furthest	DJ

Vitrolife AB Announces Resignation of Maria Forss as Senior Vice President

August 23, 2023 at 08:30 am EDT

Vitrolife AB (publ) announced that Maria Forss, has resigned from her position as SVP Consumables business area in the company as she will assume the role of CEO BICO Group AB. Maria has been employed within the company since 2012 and has been leading the Consumables business area since 2017.

Latest news about Vitrolife AB

Vitrolife AB Approves Dividend for the Financial Year 2023	Apr. 25	CI
Nordic Stocks Closed Down Thursday; Arjo Series B Fell Furthest	Apr. 18	DJ
Transcript : Vitrolife AB, Q1 2024 Earnings Call, Apr 18, 2024	Apr. 18
Vitrolife AB Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 18	CI
Memphasys Secures Additional Order for Fertility Device System in Japan; Shares Jump 9%	Mar. 17	MT
Nordic Shares Rose Monday; Vitrolife Topped Leaders	Feb. 05	DJ
Transcript : Vitrolife AB, Q4 2023 Earnings Call, Feb 02, 2024	Feb. 02
Vitrolife AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 02	CI
Vitrolife AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 02	CI
Vitrolife AB Proposes Dividend, Payable on 3 May 2024	Feb. 02	CI
Global markets live: EasyJet, Netflix, AT&T, eBay, Apple...	Jan. 24
Sweden's Vitrolife flags $409 mln impairment charge in Q4	Jan. 23	RE
Vitrolife AB Reports Non-Cash Impairment for the Fourth Quarter of 2023	Jan. 23	CI
Nordic Shares Rose Wednesday; Filo Climbed Highest	Jan. 10	DJ
Memphasys Signs Distribution Deals for Fertility System; Shares Jump 8%	Jan. 01	MT
Nordic Stocks Declined Tuesday; Vitrolife Took Biggest Hit	Dec. 12	DJ
Transcript : Vitrolife AB - Analyst/Investor Day	Dec. 12
Nordic Stocks Moved Upward Wednesday; Vimian Group Led Increases	Nov. 29	DJ
Nordic Shares Moved Upward Friday; Marel Led Increases	Nov. 24	DJ
Nordic Stocks Rose Tuesday; NEL Led Increases	23-10-31	DJ
Nordic Stocks Closed Up Monday; Munters Group Topped Leaders	23-10-30	DJ
Transcript : Vitrolife AB, Q3 2023 Earnings Call, Oct 27, 2023	23-10-27
Vitrolife AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-27	CI
Vitrolife AB Announces Election Committee Appointments	23-10-05	CI
Nordic Stocks Declined Friday; H&M Hennes & Mauritz B Took Biggest Hit	23-09-15	DJ

Chart Vitrolife AB

Duration

Period

More charts

Company Profile

Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Companyâs product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-07-12 - Q2 2024 Earnings Call

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

Vitrolife AB (publ) : A pioneer in in vitro fertilization

July 26, 2023 at 03:53 am EDT

More Strategies

Ratings for Vitrolife AB

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

163.3 SEK

Average target price

231.7 SEK

Spread / Average Target

+41.87%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
VITROLIFE AB	-16.13%	2.02B
BIOMÉRIEUX	+0.89%	12.8B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-10.29%	7.61B
DIASORIN S.P.A.	+1.78%	5.41B
AUTOBIO DIAGNOSTICS CO., LTD.	-1.16%	4.51B
LANTHEUS HOLDINGS, INC.	+5.74%	4.49B
10X GENOMICS, INC.	-50.70%	3.3B
ANDON HEALTH CO., LTD.	+12.21%	2.73B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-11.50%	1.73B
MYRIAD GENETICS, INC.	-5.02%	1.64B

Diagnostic & Testing Substances